Westport Fuel Systems (WPRT) Q4 2023 Earnings Call Transcript
WPRT earnings call for the period ending December 31, 2023.
Mindfully Curated
WPRT earnings call for the period ending December 31, 2023.
The company appears poised to enter a bidding war for a British target.
AI-related cryptocurrencies are once again seeing outsize investor interest again today.
The company secured a large and important new sales channel.
A leading Wall Street firm thinks that Seagate stock is heading for a new record high.
One product in particular could juice the company’s fundamentals, a pundit believes.
When the skeletal remains of a giant ground sloth were first unearthed in 1796, the discovery marked one of the earliest paleontological finds in American history.
Researchers have discovered a protein called SEL1L that plays a critical role in clearing collagen from tissue, and which may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function. The paper provides clues th…
A new study shows virus-like particle can effectively ‘shock and kill’ latent HIV reservoir in those living with chronic HIV.
Ludwig van Beethoven, one of the most celebrated musicians in human history, has a rather low genetic predisposition for beat synchronization, according to a new study.
Tesla’s first-quarter delivery report could shock investors.
Three out of five voters surveyed would like marijuana to be cheaper.
The podcast also dives into the situation with New York Community Bancorp.
The widely followed growth investor keeps making moves in her Ark Invest portfolios.
The stock is joining a new index.
Will this be a profitable way to grow?
Will Tesla stock fall 33%, or expand massively in Italy?
The high-flying biotech company delivered more good news about a weight loss drug candidate.
An international research team has designed and manufactured a virus-killing surface that could help control disease spread in hospitals, labs and other high-risk environments.
Researchers have identified a new potential target for the treatment of Alzheimer’s disease — PDE4B. The researchers observed that AD mice showed memory deficits in maze tests, but memory was unimpaired in AD mice with genetically reduced PDE4B activity.